Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

B. Filion, Kristian; M. Lix, Lisa; HY Yu, Oriana; Dell’Aniello, Sophie; Douros, Antonios; R. Shah, Baiju; St-Jean, Audray; Fisher, Anat; Tremblay, Éric; Bugden, Shawn; Alessi‐Severini, Silvia; E. Ronksley, Paul; Hu, Nianping; R. Dormuth, Colin; Ernst, Pierre; Suissa, Samy

doi:10.1136/bmj.m3342

Public

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

Published in BMJ • Sep 23, 2020

Authors:

Kristian B. Filion

Lisa M. Lix

Oriana HY Yu

Abstract

Abstract Objective To compare the risk of cardiovascular events between sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among people with type 2 diabetes in a real world context of clinical practice. Design Multi-database retrospective cohort study usi...

Subject

Retrospective cohort study

Medicine

Adverse effect

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!